No abstract available
Keywords:
PCSK9 antibodies; PCSK9 inhibitors; alirocumab; evolocumab.
MeSH terms
-
Cardiovascular Diseases* / drug therapy
-
Cardiovascular Diseases* / prevention & control
-
Cholesterol, LDL / blood
-
Humans
-
Hypolipidemic Agents* / administration & dosage
-
Hypolipidemic Agents* / pharmacology
-
Hypolipidemic Agents* / therapeutic use
-
PCSK9 Inhibitors*
-
Receptors, LDL
-
Serine Proteinase Inhibitors* / administration & dosage
-
Serine Proteinase Inhibitors* / pharmacology
-
Serine Proteinase Inhibitors* / therapeutic use
Substances
-
Cholesterol, LDL
-
Hypolipidemic Agents
-
PCSK9 Inhibitors
-
Receptors, LDL
-
Serine Proteinase Inhibitors
-
PCSK9 protein, human